• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Orchestra BioMed Holdings, Inc. - Ordinary Shares (NQ:OBIO)

    2.390 -0.040 (-1.65%)
    Streaming Delayed Price Updated: 3:48 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 191,300
    Open 2.420
    Bid (Size) 2.390 (7)
    Ask (Size) 2.400 (2)
    Prev. Close 2.430
    Today's Range 2.380 - 2.477
    52wk Range 2.200 - 6.500
    Shares Outstanding 38,194,442
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
     
    Via Benzinga

    Performance

    YTD
    -55.6%
    -55.6%
    1 Month
    -20.3%
    -20.3%
    3 Month
    -19.8%
    -19.8%
    6 Month
    -48.0%
    -48.0%
    1 Year
    -49.0%
    -49.0%

    More News

    Read More
    Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
    Via Benzinga
    Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Orchestra BioMed Announces Pricing of $40 Million Public Offering
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    These stocks are moving in today's after hours session
    Via Chartmill
    Orchestra BioMed Announces Proposed Public Offering
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Sidoti Events, LLC's Virtual May Micro-Cap Conference
    Via ACCESS Newswire
    Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    SmallCaps Gaining Momentum: TIVC, GELS, SLI, OBIO in Healthcare, Biotech, Energy, Military Defense, Etc. – More Stocks Inside
    Via AB Newswire
    Topics Government
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Orchestra BioMed Holdings, Inc. - Ordinary Shares publicly traded?
    Yes, Orchestra BioMed Holdings, Inc. - Ordinary Shares is publicly traded.
    What exchange does Orchestra BioMed Holdings, Inc. - Ordinary Shares trade on?
    Orchestra BioMed Holdings, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Orchestra BioMed Holdings, Inc. - Ordinary Shares?
    The ticker symbol for Orchestra BioMed Holdings, Inc. - Ordinary Shares is OBIO on the Nasdaq Stock Market
    What is the current price of Orchestra BioMed Holdings, Inc. - Ordinary Shares?
    The current price of Orchestra BioMed Holdings, Inc. - Ordinary Shares is 2.390
    When was Orchestra BioMed Holdings, Inc. - Ordinary Shares last traded?
    The last trade of Orchestra BioMed Holdings, Inc. - Ordinary Shares was at 09/26/25 03:48 PM ET
    What is the market capitalization of Orchestra BioMed Holdings, Inc. - Ordinary Shares?
    The market capitalization of Orchestra BioMed Holdings, Inc. - Ordinary Shares is 91.28M
    How many shares of Orchestra BioMed Holdings, Inc. - Ordinary Shares are outstanding?
    Orchestra BioMed Holdings, Inc. - Ordinary Shares has 91M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.